Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. (r*,s*)-4,4'-(2,3-dimethylbutane-1,4-diyl)bispyrocatechol
2. Acid, Meso-nordihydroguaiaretic
3. Actinex
4. Dihydronorguaiaretic Acid
5. Meso Nordihydroguaiaretic Acid
6. Meso-nordihydroguaiaretic Acid
7. Nordihydroguaiaretic Acid
8. Nordihydroguaiaretic Acid, (r*,s*)-isomer
1. Meso-ndga
2. 27686-84-6
3. Meso-nordihydroguaiaretic Acid
4. Actinex
5. Masoprocolum
6. Masoprocolum [inn-latin]
7. Chx 100
8. Chx-100
9. Meso-4,4'-(2,3-dimethyltetramethylene)dipyrocatechol
10. 1,2-benzenediol, 4,4'-(2,3-dimethyl-1,4-butanediyl)bis-, (r*,s*)-
11. 4,4'-((2r,3s)-2,3-dimethylbutane-1,4-diyl)bis(benzene-1,2-diol)
12. Nordihydroguaiaretic Acid From Larrea Divaricata (creosote Bush)
13. 7bo8g1byqu
14. Insm18
15. Insm-18
16. Chembl313972
17. Erythro-nordihydroguaiaretic Acid
18. Chebi:73468
19. 4-[(2s,3r)-4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol
20. Nsc-4291
21. Nsc-682984
22. Meso-2,3-bis(3,4-dihydroxyphenylmethyl)butane
23. Meso-1,4-bis(3,4-dihydroxyphenyl)-2,3-dimethylbutane
24. Meso-4,4'-(2,3-dimethyl-1,4-butanediyl)bis(pyrocatechol)
25. Nordihydroguaiaretate
26. Masoprocol [usan:inn]
27. Meso-4-[4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol
28. Meso-beta,gamma-dimethyl-alpha,delta-bis(3,4-dihydroxyphenyl)butan
29. 1,2-benzenediol, 4,4'-((2r,3s)-2,3-dimethyl-1,4-butanediyl)bis-, Rel-
30. 1,2-benzenediol, 4,4'-[(2r,3s)-2,3-dimethyl-1,4-butanediyl]bis-, Rel-
31. 4-[(2r,3s)-4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol
32. 4-[(2s,3r)-3-[(3,4-dihydroxyphenyl)methyl]-2-methylbutyl]benzene-1,2-diol
33. Nordihydroguiaretic Acid
34. Einecs 248-606-6
35. Unii-7bo8g1byqu
36. Nordihydroguaiaretic Acid (ndga)
37. (r*,s*)-4,4'-(2,3-dimethylbutane-1,4-diyl)bispyrocatechol
38. 4-((2r,3s)-4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl)benzene-1,2-diol
39. Ncgc00015741-06
40. Actinex (tn)
41. Nordihydroguaiaretic Acid (meso-form)
42. Nordihydroguaiaretsaure
43. Oristar Nhga
44. Masoprocol [inn]
45. Masoprocol (usan/inn)
46. Lopac-n-5023
47. Masoprocol [usan]
48. Masoprocol [vandf]
49. Masoprocol [mart.]
50. Schembl3818
51. Dsstox_cid_25178
52. Dsstox_rid_80726
53. Masoprocol [who-dd]
54. Dsstox_gsid_45178
55. Lopac0_000877
56. Bidd:er0127
57. Dtxsid5045178
58. Masoprocol [orange Book]
59. Rel-4,4'-((2r,3s)-2,3-dimethylbutane-1,4-diyl)bis(benzene-1,2-diol)
60. Bdbm22372
61. Masoprocol (nordihydroguaiaretic)
62. Zinc12342
63. Hms3262p15
64. Tnp00263
65. Tox21_110210
66. Tox21_500877
67. Nordihydroguaiaretic Acid [mi]
68. Akos016014015
69. Ccg-204959
70. Db00179
71. Lp00877
72. Nordihydroguaiaretic Acid [inci]
73. Ncgc00015741-01
74. Ncgc00015741-02
75. Ncgc00015741-03
76. Ncgc00015741-07
77. Ncgc00094201-01
78. Ncgc00094201-02
79. Ncgc00094201-03
80. Ncgc00094201-04
81. Ncgc00094201-05
82. Ncgc00094201-06
83. Ncgc00261562-01
84. Nordihydroguaiaretic Acid [who-dd]
85. Cas-27686-84-6
86. Hy-109500
87. Cs-0031186
88. Eu-0100877
89. D04862
90. N 5023
91. 686b846
92. Sr-01000076028
93. Ncgc00015741-06!nordihydroguaiaretic Acid
94. Q6783851
95. Sr-01000076028-1
96. Meso-4,4'-(2,3-dimethyltetrameth-ylene)dipyrocatechol
97. 4,4'-[(2r,3s)-2,3-dimethyl-1,4-butanediyl]biscatechol
98. 4,4'-((2r,3s)-2,3-dimethylbutane-1,4-diyl)dibenzene-1,2-diol
99. 4-[(2r,3s)-4-(3,4-dihydroxyphenyl)-2,3-dimethyl-butyl]benzene-1,2-diol
100. 1050512-02-1
Molecular Weight | 302.4 g/mol |
---|---|
Molecular Formula | C18H22O4 |
XLogP3 | 4.3 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 5 |
Exact Mass | 302.15180918 g/mol |
Monoisotopic Mass | 302.15180918 g/mol |
Topological Polar Surface Area | 80.9 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 303 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Used for the treatment of actinic keratoses (precancerous skin growths that can become malignant if left untreated).
Masoprocol is a novel antineoplastic agent. It is not known exactly how masoprocol works. Laboratory experiments have shown that masoprocol prevents cells similar to the ones found in actinic keratoses from multiplying. Masoprocol was withdrawn from the U.S. market in June 1996.
Antioxidants
Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)
Lipoxygenase Inhibitors
Compounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES. (See all compounds classified as Lipoxygenase Inhibitors.)
Cyclooxygenase Inhibitors
Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)
L - Antineoplastic and immunomodulating agents
L01 - Antineoplastic agents
L01X - Other antineoplastic agents
L01XX - Other antineoplastic agents
L01XX10 - Masoprocol
Absorption
Less than 1%-2% is absorbed through the skin over a 4-day period following application.
Although the exact mechanism of action is not known, studies have shown that masoprocol is a potent 5-lipoxygenase inhibitor and has antiproliferative activity against keratinocytes in tissue culture, but the relationship between this activity and its effectiveness in actinic keratoses is unknown. Masoprocol also inhibits prostaglandins but the significance of this action is not yet known.
ABOUT THIS PAGE
32
PharmaCompass offers a list of Masoprocol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Masoprocol manufacturer or Masoprocol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Masoprocol manufacturer or Masoprocol supplier.
PharmaCompass also assists you with knowing the Masoprocol API Price utilized in the formulation of products. Masoprocol API Price is not always fixed or binding as the Masoprocol Price is obtained through a variety of data sources. The Masoprocol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Masoprocol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Masoprocol, including repackagers and relabelers. The FDA regulates Masoprocol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Masoprocol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Masoprocol supplier is an individual or a company that provides Masoprocol active pharmaceutical ingredient (API) or Masoprocol finished formulations upon request. The Masoprocol suppliers may include Masoprocol API manufacturers, exporters, distributors and traders.
click here to find a list of Masoprocol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Masoprocol DMF (Drug Master File) is a document detailing the whole manufacturing process of Masoprocol active pharmaceutical ingredient (API) in detail. Different forms of Masoprocol DMFs exist exist since differing nations have different regulations, such as Masoprocol USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Masoprocol DMF submitted to regulatory agencies in the US is known as a USDMF. Masoprocol USDMF includes data on Masoprocol's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Masoprocol USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Masoprocol suppliers with USDMF on PharmaCompass.
Masoprocol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Masoprocol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Masoprocol GMP manufacturer or Masoprocol GMP API supplier for your needs.
A Masoprocol CoA (Certificate of Analysis) is a formal document that attests to Masoprocol's compliance with Masoprocol specifications and serves as a tool for batch-level quality control.
Masoprocol CoA mostly includes findings from lab analyses of a specific batch. For each Masoprocol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Masoprocol may be tested according to a variety of international standards, such as European Pharmacopoeia (Masoprocol EP), Masoprocol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Masoprocol USP).